Clinical Genomics, European Institute of Oncology IRCCS, Milan, Italy.
Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
PLoS One. 2022 Jan 31;17(1):e0263014. doi: 10.1371/journal.pone.0263014. eCollection 2022.
The correlation between immune responses and protection from SARS-CoV-2 infections and its duration remains unclear. We performed a sanitary surveillance at the European Institute of Oncology (IEO) in Milan over a 17 months period. Pre-vaccination, in 1,493 participants, we scored 266 infections (17.8%) and 8 possible reinfections (3%). Post-vaccination, we identified 30 infections in 2,029 vaccinated individuals (1.5%). We report that the probability of infection post-vaccination is i) significantly lower compared to natural infection, ii) associated with a significantly shorter median duration of infection than that of first infection and reinfection, iii) anticorrelated with circulating antibody levels.
我们在米兰的欧洲肿瘤研究所(IEO)进行了为期 17 个月的卫生监测。在接种疫苗前,我们对 1493 名参与者进行了评分,发现 266 人(17.8%)感染,8 人可能再次感染(3%)。接种疫苗后,我们在 2029 名接种疫苗的个体中发现了 30 例感染(1.5%)。我们报告称,接种疫苗后的感染概率为:i)与自然感染相比显著降低,ii)与首次感染和再次感染的感染持续时间相比显著缩短,iii)与循环抗体水平呈负相关。